Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and csDMARDs T2T in Ankylosing Spondylitis
NCT04077957Phase 4Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Oct 2019
- Primary completion
- Oct 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of anbainuo in ankylosing spondylitis (AS), spondyloarthritis (SpA), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
anbainuo
03
Conditions
ankylosing spondylitis (AS)spondyloarthritis (SpA)
Beyond the preview
Go deeper on NCT04077957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04077957.